Hanson & Doremus Investment Management Sells 365 Shares of McKesson Co. (NYSE:MCK)

Hanson & Doremus Investment Management cut its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 10.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,182 shares of the company's stock after selling 365 shares during the quarter. Hanson & Doremus Investment Management's holdings in McKesson were worth $2,141,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of MCK. Capital A Wealth Management LLC acquired a new stake in shares of McKesson during the fourth quarter worth $26,000. Millstone Evans Group LLC acquired a new stake in shares of McKesson during the fourth quarter worth $28,000. Atala Financial Inc acquired a new stake in shares of McKesson during the fourth quarter worth $34,000. Graney & King LLC acquired a new stake in shares of McKesson during the fourth quarter worth $38,000. Finally, Creative Capital Management Investments LLC acquired a new stake in shares of McKesson during the fourth quarter worth $44,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other McKesson news, CEO Brian S. Tyler sold 19,370 shares of McKesson stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $705.93, for a total value of $13,673,864.10. Following the sale, the chief executive officer now owns 51,243 shares of the company's stock, valued at approximately $36,173,970.99. The trade was a 27.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Leann B. Smith sold 341 shares of McKesson stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $717.91, for a total transaction of $244,807.31. Following the completion of the sale, the executive vice president now directly owns 2,800 shares in the company, valued at approximately $2,010,148. This represents a 10.86% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,117 shares of company stock valued at $23,526,451. Company insiders own 0.11% of the company's stock.

McKesson Price Performance

MCK opened at $727.15 on Monday. The company's 50-day moving average is $703.28 and its 200 day moving average is $644.62. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $732.99. The firm has a market capitalization of $90.98 billion, a P/E ratio of 33.29, a PEG ratio of 1.29 and a beta of 0.49.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The company had revenue of $90.82 billion for the quarter, compared to analyst estimates of $94 billion. During the same period last year, the firm earned $6.18 earnings per share. The firm's revenue was up 18.9% on a year-over-year basis. On average, equities research analysts expect that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, June 2nd. McKesson's payout ratio is currently 10.99%.

Wall Street Analyst Weigh In

MCK has been the subject of several recent analyst reports. Bank of America increased their price objective on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. UBS Group raised their price target on shares of McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Cfra Research cut shares of McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Wall Street Zen cut shares of McKesson from a "strong-buy" rating to a "buy" rating in a report on Saturday. Finally, Wells Fargo & Company set a $766.00 price target on shares of McKesson and gave the stock an "equal weight" rating in a report on Tuesday, June 3rd. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $694.38.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.